Advanced Solid Tumors
3 competing products in clinical development for Advanced Solid Tumors.
Pipeline by Phase
Phase 13
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| IMC-18F1 | Eli Lilly | Phase 1 | Completed | 33 |
| SY-1365 (Part 1) + Carboplatin + Fulvestrant + SY-1365 (Cohort 2) + SY-1365 (Cohort 5) + SY-1365 (Part 2 Single Agent) | Syros Pharmaceuticals | Phase 1 | Terminated | 25 |
| OKI-179 | OnKure Therapeutics | Phase 1 | Completed | 25 |